Gong, Mingkun
Xu, Ke
Shan, Yongzhi
Wang, Yihe
Zhang, Chao
Wang, Xiongfei
Zhou, Jian
Guan, Yuguang
Li, Tianfu
Luan, Guoming
Funding for this research was provided by:
Capital Foundation of Medical Development (2022-1-8011)
Article History
Received: 13 February 2023
Accepted: 29 April 2023
First Online: 9 June 2023
Declarations
:
: This study protocol has been approved by the Ethics Committee of Sanbo Brain Hospital, Capital Medical University (SBNK-YJ-2022-006-01). Other participating sub-centers had also obtained approval from the ethics committee prior to the initiation of the study.All participants or their legal guardians will receive information about the study orally and in writing through members of the research team. The benefits and potential risks to their health will be highlighted. All participants or their legal guardians need to sign a written informed consent form. On the consent form, participants will be asked if they agree to the use of their data should they choose to withdraw from the trial. Participants will also be asked for permission for the research team to share relevant data with people taking part in the research or from regulatory authorities. This trial does not involve collecting biological specimens for storage.
: Not applicable.
: The authors declare that they have no competing interests.